Modeling HTLV-1 infection and cellular immune response in HLA-A2-transgenic mice

HLA-A2 转基因小鼠的 HTLV-1 感染和细胞免疫反应建模

基本信息

  • 批准号:
    8070131
  • 负责人:
  • 金额:
    $ 19.28万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-12-01 至 2012-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): To date, the lack of a suitable small animal model has hindered our quest to understand the immuno- and neuropathogenesis of HTLV-1 in an in vivo system. This is due to the inefficient fusion of HTLV-1 envelope with murine cells. Recently, a chimeric HTLV-1 virus has been developed that utilizes the envelope gene of the Moloney-murine leukemia virus thereby allowing fusion of the chimeric virus with murine cells. Utilizing this chimeric virus we have recently demonstrated that depletion of DCs enhances susceptibility to cell-free infection of HTLV-1 in CD11c-DTR-transgenic mice (Rahman et al., J. Immunol, in press). These mice are uniquely designed to selectively deplete DCs in vivo. Murine cells, unlike simian and human cells, are generally refractive to diphtheria toxin (DT). The fusion of DTR transgene to the CD11c promoter (largely expressed in murine splenic DCs) in CD11c-DTR-Tg mice allows for the complete ablation of DCs in the presence of DT without affecting other APCs such as B cells and macrophages. This system has been used to study role of DCs in the pathogenesis of several viruses including LCMV, HSV-1, and recently HTLV-1 (Rahman et al., J. Immunol., in press). However, these mice still pose problem in studying human MHC class I-associated immune responses (such as those observed in HAM/TSP patients) due to the mouse MHC background. This issue has been addressed in a separate strain of mice, known as line HHD II, which express human HLA-A2.1 molecule and are knockout for the mouse H-2Db MHC class I molecule and beta2-microglobulin thereby carrying only human HLA class I molecules. We have previously demonstrated the immunization and induction of Tax 11-19-specific CTL response in these mice (Manuel et al., J. Leuk. Biol., 2009). The study proposed herein attempts to generate a new transgenic strain (HHD II/DTR-Tg) of mice to study HTLV-1 infection and subsequent HLA-A2-restrticted cellular immune response in the absence and presence of DCs. The newly generated strain could be further utilized to investigate mechanistic aspects of DC:T cell interaction during HTLV-1-mediated immunopathogenesis. The ability to selectively ablate DCs in vivo offers a powerful tool to explore the role of this unique cell population in various infection and disease models. The development of a new hybrid strain (HHD II/DTR-Tg), as proposed here, will greatly facilitate future studies of HTLV-1 immuno/neuropathogenesis in addition to providing a valuable tool to the scientific community in general. PUBLIC HEALTH RELEVANCE: The proposed studies are relevant to public health and will reveal significant information concerning the dendritic cells-regulated T cell responses during complex autoimmune/neuroinflammatory diseases such as HAM/TSP and multiple sclerosis. Additionally the results of these studies will shed light on the dynamics of immune cell interactions during chronic viral infections such as HTLV-1, HIV-1, hepatitis virus and herpes simplex virus.
描述(由申请人提供):迄今为止,缺乏合适的小动物模型阻碍了我们在体内系统中理解HTLV-1的免疫和神经发病机制的探索。这是由于HTLV-1包膜与鼠细胞的低效融合。最近,已经开发了一种嵌合HTLV-1病毒,其利用了Moloney-鼠白血病病毒的包膜基因,从而允许嵌合病毒与鼠细胞融合。利用这种嵌合病毒,我们最近证明了DC的消耗增强了CD 11 c-DTR转基因小鼠对HTLV-1的无细胞感染的易感性(Rahman等人,J. Immunol,出版中)。这些小鼠被独特地设计为选择性地消耗体内DC。与猿和人类细胞不同,鼠细胞通常对白喉毒素(DT)具有折射性。在CD 11 c-DTR-Tg小鼠中,DTR转基因与CD 11 c启动子(主要在鼠脾DC中表达)的融合允许在DT存在下完全消融DC,而不影响其他APC如B细胞和巨噬细胞。该系统已用于研究DC在几种病毒(包括LCMV、HSV-1和最近的HTLV-1)的发病机制中的作用(Rahman等人,免疫学杂志,印刷中)。然而,由于小鼠MHC背景,这些小鼠在研究人MHC I类相关免疫应答(例如在HAM/TSP患者中观察到的那些)中仍然存在问题。这个问题已经在一个单独的小鼠品系中得到解决,称为HHD II系,其表达人HLA-A2.1分子,并且敲除小鼠H-2Db MHC I类分子和β 2-微球蛋白,从而仅携带人HLA I类分子。我们先前已经证明了在这些小鼠中Tax 11-19特异性CTL应答的免疫和诱导(Manuel等人,勒克。生物学:2009年)。本文提出的研究试图产生一种新的转基因小鼠品系(HHD II/DTR-Tg),以研究在DC存在和不存在的情况下HTLV-1感染和随后的HLA-A2限制的细胞免疫应答。新产生的菌株可进一步用于研究HTLV-1介导的免疫发病过程中DC:T细胞相互作用的机制方面。在体内选择性消融DC的能力为探索这种独特的细胞群在各种感染和疾病模型中的作用提供了有力的工具。一个新的杂交株(HHD II/DTR-Tg)的发展,这里提出,将大大促进未来的研究HTLV-1免疫/神经发病机制,除了提供一个有价值的工具,科学界一般。 公共卫生相关性:拟议的研究与公共卫生有关,并将揭示有关树突状细胞调节的T细胞反应在复杂的自身免疫性/神经炎症性疾病,如HAM/TSP和多发性硬化症的重要信息。此外,这些研究的结果将揭示慢性病毒感染期间免疫细胞相互作用的动力学,如HTLV-1,HIV-1,肝炎病毒和单纯疱疹病毒。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ZAFAR K KHAN其他文献

ZAFAR K KHAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ZAFAR K KHAN', 18)}}的其他基金

Modeling HTLV-1 infection and cellular immune response in HLA-A2-transgenic mice
HLA-A2 转基因小鼠的 HTLV-1 感染和细胞免疫反应建模
  • 批准号:
    8197542
  • 财政年份:
    2010
  • 资助金额:
    $ 19.28万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 19.28万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.28万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 19.28万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.28万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 19.28万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.28万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 19.28万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 19.28万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 19.28万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.28万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了